Ukko Company
We are building a comprehensive, clinically validated map of the molecular structure of food allergies and disorders, unlocking critical knowledge about the biological mechanisms that drive human food interactions.
On the basis of this map, we design proteins that do not trigger an immune response. These proteins are then applied to the food and therapeutics markets.
On the basis of this map, we design proteins that do not trigger an immune response. These proteins are then applied to the food and therapeutics markets.
Technology:
Biotech
Industry:
FoodScience
Headquarters:
Palo Alto, California, United States
Founded Date:
01.01.2016
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
8
Total Funding:
$47,699,997
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-01-27
Last Funding Type:
Series B
Register and Claim Ownership